The Synthesis of 6-Deazaformycin
A

Tony Tite; Nikolaos Lougiakis; Panagiotis Marakos; Nicole Pouli

doi:10.1055/s-0029-1218002

LETTER

The Synthesis of 6-Deazaformycin A

Tony Tite, Nikolaos Lougiakis, Panagiotis Marakos, Nicole Pouli*
Department of Pharmacy, Division of Pharmaceutical Chemistry, University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece
Fax: +30(210)7274747; e-Mail: pouli@pharm.uoa.gr;

Abstract

All articles of this category

Abstract

The synthesis of the new C-nucleoside 6-deazaformycin A was achieved through the condensation of a suitably substituted lithiated 2-picoline with 2,3,5-tri-O-benzyl-d-ribonolactone, borohydride reduction of the resulting hemiacetals, followed by intramolecular Mitsunobu cyclization of the carbinols, manipulation of the protecting groups, and subsequent ring closure to result in the formation of 7-amino-3-(β-d-ribofuranosyl)pyrazolo[4,3-b]pyridine.

Key words

C-nucleosides - heterocycles - formycin A - pyrazolo[4,3-b]pyridine

Full Text

References

References and Notes

<A NAME="RD19309ST-1">1</A> Watanabe KA. In Chemistry of Nucleosides and Nucleotides Vol. 3: Townsend LB. Plenum Press; New York: 1994. p.421-535

<A NAME="RD19309ST-2A">2a</A> Hori M. Ito E. Takita T. Umezawa H. J. Antibiot., Ser. A 1964, 17: 96

<A NAME="RD19309ST-2B">2b</A> Koyama G. Umezawa H.
J. Antibiot. Ser. A 1965, 18: 175

<A NAME="RD19309ST-3A">3a</A> Bzowska A. In Modified Nucleosides in Biochemistry, Biotechnology and Medicine Herdewijn P. Wiley; New York: 2008. p.473-510

<A NAME="RD19309ST-3B">3b</A> Hidaka T. Katayama K. Yamashita K. Yamashita T. Watanabe K. Shimazaki M. Ohno M. Takeuchi T. Umezawa H. J. Antibiot. 1980, 33: 303

<A NAME="RD19309ST-3C">3c</A> Rosowsky A. Solan VC. Gudas LJ. J. Med. Chem. 1986, 28: 1096

<A NAME="RD19309ST-3D">3d</A> Giziewicz J. De Clercq E. Luczak M. Shugar D. Biochem. Pharmacol. 1975, 24: 1813

<A NAME="RD19309ST-3E">3e</A> Orozco M. Canela EI. Franco R. Mol. Pharmacol. 1989, 35: 257

<A NAME="RD19309ST-4">4</A> Malaisse WJ. Sener A. Gruber HE. Erion MD. Biochem. Med. Metabolic Biol. 1994, 53: 22

<A NAME="RD19309ST-5">5</A> Ishizuka M. Sawa T. Koyama G. Takeuchi T. Umezawa H. J. Antibiot. 1968, 21: 1

<A NAME="RD19309ST-6">6</A> Upadhya KG. Sanghvi YS. Robins RK. Revankar GR. Ugarkar BG. Nucleic Acids Res. 1986, 25: 1747

<A NAME="RD19309ST-7">7</A> Secrist JA. Shortnacy AT. Montgomery JA.
J. Med. Chem. 1985, 28: 1740

<A NAME="RD19309ST-8">8</A> Liu M.-C. Luo M.-Z. Mozdziesz DE. Sartorelli AC. Nucleosides, Nucleotides Nucleic Acids 2005, 24: 45

<A NAME="RD19309ST-9">9</A> Ramasamy K. Ugarkar BG. McKernan PA. Robins RK. Revankar GR. J. Med. Chem. 1986, 29: 2231

<A NAME="RD19309ST-10A">10a</A> Kourafalos VN. Marakos P. Pouli N. Townsend LB. Synlett 2002, 1479

<A NAME="RD19309ST-10B">10b</A> Kourafalos VN. Marakos P. Pouli N. Townsend LB. J. Org Chem. 2003, 68: 6466

<A NAME="RD19309ST-10C">10c</A> Korouli S. Lougiakis N. Marakos P. Pouli N. Synlett 2008, 181

<A NAME="RD19309ST-11A">11a</A> Cousineau TJ. Secrist JA. J. Org. Chem. 1979, 44: 4351

<A NAME="RD19309ST-11B">11b</A> Timpe W. Dax K. Wolf N. Weidmann H. Carbohydr. Res. 1975, 69: 51

<A NAME="RD19309ST-12">12</A> Reich MF. Fabio PF. Lee VJ. Kuck NA. Testa RT. J. Med. Chem. 1989, 32: 2474

<A NAME="RD19309ST-13A">13a</A> Deady LW. Korytsky OL. Rowe JE. Aust. J. Chem. 1982, 35: 2025

<A NAME="RD19309ST-13B">13b</A> Indumathy M. Malcolm R. J. Heterocycl. Chem. 1992, 29: 359

<A NAME="RD19309ST-14">14</A> Guianvarc’h D. Fourrey J.-L. Tran Huu Dau M.-E. Guerineau V. Benhida R. J. Org. Chem. 2002, 67: 3724

Data for tert -Butyl- N -[3-amino-2-(2,3,5-tri- O -benzyl-β- d -ribofuranosylmethyl)pyridin-4-yl]carbamate (14)
Oil. ^¹H NMR (400 MHz, CDCl₃): δ = 1.55 (s, 9 H, t-Bu), 3.00 (dd, 1 H, 2-CH₂, J = 7.33, 13.69 Hz), 3.10 (dd, 1 H, 2-CH₂, J = 3.91, 13.69 Hz), 3.42 (dd, 1 H, H-5′, J₅ _′ _,4 _′ = 4.40 Hz, J ₅ _′ _,5 _′ = 10.27 Hz), 3.45-3.56 (br s, 2 H, D₂O exchange, NH₂), 3.56 (dd, 1 H, H-5′, J ₅ _′ _,4 _′ = 2.94 Hz, J ₅ _′ _,5 _′ = 10.27 Hz), 3.72 (t, 1 H, H-3′, J = 5.87 Hz), 3.92 (t, 1 H, H-2′, J = 4.40 Hz), 4.16-4.21 (m, 1 H, H-4′), 4.38-4.68 (m, 7 H, H-1′, 6 × CH₂Ph), 6.91 (s, 1 H, D₂O exchange, NHBoc), 7.23-7.41 (m, 15 H, 3 × C₆H₅), 7.63 (d, 1 H, H-5, J _5,6 = 5.38 Hz), 8.05 (d, 1 H, H-6, J _6,5 = 5.38 Hz). ^¹³C NMR (50 MHz CDCl₃): δ = 28.40 [(CH₃)₃CCONH], 39.34 (CH₂), 69.64 (C-5′), 72.08, 73.41 (CH₂Ph), 77.16 (C-3′), 79.61 (C-2′), 80.52 (C-4′), 81.29 [(CH₃)₃ CCONH], 82.60 (C-1′), 112.73 (C-5), 127.80, 127.88, 128.14, 128.45, 128.54 (tertiary benzylic CH), 130.80 (C-3), 136.62 (C-4), 137.93, 138.09, 138.16 (quaternary benzylic C), 142.27 (C-6), 148.53 (C-2),152.58 (CO).

<A NAME="RD19309ST-16">16</A> Kourafalos VN. Marakos P. Pouli N. Terzis A. Townsend LB. Heterocycles 2002, 57: 2335

<A NAME="RD19309ST-17">17</A> Marakos P. Pouli N. Wise D. Townsend LB. Synlett 1997, 561

<A NAME="RD19309ST-18">18</A> Chapman D. Hurst J. J. Chem. Soc., Perkin Trans. 1 1980, 2398

<A NAME="RD19309ST-19">19</A> Jones G. Adv. Heterocycl. Chem. 2002, 83: 1

Data for 7-Amino-(3-β- d -ribofuranosyl)pyrazolo[4,3- b ]pyridine (30)
Pale yellow foam. ^¹H NMR (400 MHz, CD₃OD): δ = 3.82 (dd, 1 H, H-5′, J ₅ _′ _,4 _′ = 12.13 Hz, J ₄ _′ _,5 _′′ = 2.35 Hz), 3.94 (dd, 1 H, H-5′, J ₅ _′ _,4 _′ = 12.13 Hz, J ₄ _′ _,5 _′′ = 2.74 Hz), 4.15-4.19 (m, 1 H, H-4′), 4.28 (dd, 1 H, H-3′, J ₃ _′ _,2 _′ = 5.08 Hz, J ₃ _′ _,4 _′′ = 3.52 Hz), 4.48 (dd, 1 H, H-2′, J ₂ _′ _,3 _′ = 5.08 Hz, J ₂ _′ _,1 _′′ = 7.04 Hz), 5.22 (d, 1 H, H-1′, J ₁ _′ _,2 _′′ = 7.04 Hz), 6.65 (d, 1 H, H-6, J _6,5 = 5.86 Hz), 8.07 (d, 1 H, H-5, J _5,6 = 5.86 Hz). ^¹³C NMR (50 MHz, CD₃OD): δ = 63.28 (C-5′), 73.74 (C-3′), 77.50 (C-2′), 80.80 (C-1′), 87.16 (C-4′), 102.89 (C-6), 129.15 (C-7α), 132.90 (C-3α), 143.15 (C-5), 143.22 (C-3), 146.97 (C-7). Anal. Calcd for C₁₁H₁₄N₄O₄: C, 49.62; H, 5.30; N, 21.04. Found: C, 49.81; H, 5.22; N, 20.87.

Data for 4-[(β- d -Ribofuranosyl)methyl]-3 H -[1,2,3]triazolo[4,5- c ]pyridine (31)
Oil. ^¹H NMR (400 MHz, CDCl₃): δ = 3.52-3.63 (m, 2 H, CH₂, H-5′), 3.65-3.74 (m, 2 H, CH₂, H-5′), 3.80-3.86 (m, 1 H, H-4′), 4.02 (t, 1 H, H-3′), 4.17 (t, 1 H, H-2′), 4.30-4.37 (m, 1 H, H-1′), 7.81 (d, 1 H, H-7, J _7,6 = 6.26 Hz), 8.30 (d,
1 H, H-6, J _6,7 = 6.26 Hz). ^¹³C NMR (50 MHz CDCl₃): δ = 38.49 (CH₂), 62.64 (C-5′), 72.21 (C-3′), 76.64 (C-2′), 83.41 (C-4′), 85.95 (C-1′), 109.07 (C-7), 139.48 (C-6), 142.29 (C-3α), 144.67 (C-7α), 153.13 (C-4). Anal. Calcd for C₁₁H₁₄N₄O₄: C, 49.62; H, 5.30; N, 21.04. Found: C, 49.55; H, 5.09; N, 21.18.